July 2023 Issue Table Of Contents

From The Editor

• More Than A Seat At The Table

Feature Articles

• I-MAK’s Quest To Trim The Biopharmaceutical Patent Thicket
• Civica Takes On Insulin Market, Opens Manufacturing Facility

Companies To Watch

• Kinaset Therapeutics

CEO Corner

• Facing The Drug Launch Challenge As A New CEO

Industry Research

• Cell & Gene Therapies Manufacturing Market Outlook

Podcast Summary

• Inside M&A With Bill Symonds

Inside The Industry

• Ways To Face New Bio Funding & Banking Risks
• Debunking BYOD Myths In Clinical Trials
• Beyond The Guidance: Business Benefits From Change Management
• Your Consultants, Your Destiny
• FDA’s Digital Health Technologies Framework Addresses Important Challenges
• Insights Into The FDA’s Guidance On Managing Drug Supply
• India's CROs & CDMOs Come Of Age In The Global Marketplace
• What Life Sciences Startups Can Do About Market Swings
• New Ways To Approach Your Next Tech Transfer

Leadership Lessons

• How To Show Up More Fully To Create Change

Ask The Board

• What Strategies Can Biotech Executives Use To Effectively Prioritize And De-Risk Development Programs During Tough Economic Times?
• Given The Increase In Size Of The Industry And The Challenge Of Fundraising, Are There Other Ways To Think About Raising Capital?